<DOC>
	<DOCNO>NCT02540226</DOCNO>
	<brief_summary>Tranexamic acid ( TXA ) drug use frequently Hospital Special Surgery lessen amount blood loss total knee replacement ( TKR ) . It anti-fibrinolytic agent , mean promotes formation blood clot . TXA give either intravenously topically ( place directly open wound ) wound closure . Patients certain medical condition find high risk thrombosis give intravenous TXA , may lead serious complication . However , date , high-risk patient identify use topical TXA . This study look thrombogenic marker ( protein find blood promote clot formation ) TXA give either intravenously topically . If effect marker similar intravenous topical use TXA , safety topical TXA question . Of note , marker never measure TXA give topically . As result , information would important medical community .</brief_summary>
	<brief_title>Effect Topical Intravenous Tranexamic Acid ( TXA ) Thrombogenic Markers Patients Undergoing Knee Replacement</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients undergo primary unilateral total knee replacement participate surgeon Patients age 1880 All patient steroid therapy regardless dose , duration , treatment require stressdose steroid preoperatively Patients require postoperative use Coumadin , Xarelto , Plavix Use nonsteroidal antiinflammatory drug ( NSAIDs ) within 1 week surgery Hypersensitivity tranexamic acid Renal dysfunction ( Creatinine clearance &lt; 40 ml/min ) Hepatic dysfunction ( AST ALT 2x upper limit normal ) Cardiac exclusion : coronary stent , history myocardial infarction , positive stress test , atrial fibrillation , advance coronary artery disease Advanced chronic obstructive pulmonary disease advance interstitial lung disease History venous thromboembolism Hypercoagulability ( e.g . antiphospholipid syndrome , genetic hypercoagulability without prior venous thromboembolism ) History stroke transient ischemic attack</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Total Knee Arthroplasty</keyword>
	<keyword>Total Knee Replacement</keyword>
</DOC>